These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 10050241
1. Etiology of Dupuytren's disease. Yi IS, Johnson G, Moneim MS. Hand Clin; 1999 Feb; 15(1):43-51, vi. PubMed ID: 10050241 [Abstract] [Full Text] [Related]
2. The role of the fibroblast in Dupuytren's contracture. Murrell GA. Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989 [Abstract] [Full Text] [Related]
3. An insight into Dupuytren's contracture. Murrell GA. Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255 [Abstract] [Full Text] [Related]
4. [Formal genesis of Dupuytren's contracture as a guide to adequate therapy]. Lösch GM. Chirurg; 1973 Mar; 44(3):131-6. PubMed ID: 4540521 [No Abstract] [Full Text] [Related]
6. A survey of clinical manifestations and risk factors in women with Dupuytren's disease. Degreef I, Steeno P, De Smet L. Acta Orthop Belg; 2008 Aug; 74(4):456-60. PubMed ID: 18811027 [Abstract] [Full Text] [Related]
8. [Etiology of Dupuytren's contracture]. Bobiński R. Chir Narzadow Ruchu Ortop Pol; 2008 Aug; 73(4):232-5. PubMed ID: 18847012 [Abstract] [Full Text] [Related]
9. New insights in the development of Dupuytren's contracture: a review. Kloen P. Br J Plast Surg; 1999 Dec; 52(8):629-35. PubMed ID: 10658134 [Abstract] [Full Text] [Related]
10. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts. Shin SS, Liu C, Chang EY, Carlson CS, Di Cesare PE. J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229 [Abstract] [Full Text] [Related]
11. [Dupuytren's contracture]. Nagay B. Wiad Lek; 1970 Nov 15; 23(22):1979-83. PubMed ID: 4922139 [No Abstract] [Full Text] [Related]
12. Dupuytren's contracture: emerging insight into a Viking disease. Nunn AC, Schreuder FB. Hand Surg; 2014 Nov 15; 19(3):481-90. PubMed ID: 25288296 [Abstract] [Full Text] [Related]
13. Epidemiology of Dupuytren's disease. Ross DC. Hand Clin; 1999 Feb 15; 15(1):53-62, vi. PubMed ID: 10050242 [Abstract] [Full Text] [Related]
14. Dupuytren's contracture--a survey of a hospital population. Rafter D, Kenny R, Gilmore M, Walsh CH. Ir Med J; 1980 Jun 15; 73(6):227-8. PubMed ID: 7399858 [No Abstract] [Full Text] [Related]
15. [Epilepsy and Dupuytren's contracture--a syntropy of 2 diseases?]. Stuhler T, Stankovic P, Ritter G, Schmulder E. Handchirurgie; 1977 Jun 15; 9(4):219-23. PubMed ID: 615080 [Abstract] [Full Text] [Related]
16. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. J Surg Res; 2002 Apr 15; 103(2):146-52. PubMed ID: 11922728 [Abstract] [Full Text] [Related]
17. Clinical associations of Dupuytren's disease. Hart MG, Hooper G. Postgrad Med J; 2005 Jul 15; 81(957):425-8. PubMed ID: 15998816 [Abstract] [Full Text] [Related]
18. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel. Bisson MA, Beckett KS, McGrouther DA, Grobbelaar AO, Mudera V. J Hand Surg Am; 2009 Jul 15; 34(6):1102-10. PubMed ID: 19505772 [Abstract] [Full Text] [Related]
19. Factors in the pathogenesis of Dupuytren's contracture. Al-Qattan MM. J Hand Surg Am; 2006 Nov 15; 31(9):1527-34. PubMed ID: 17095386 [Abstract] [Full Text] [Related]